The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Avanafil market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Avanafil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Avanafil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Avanafil include VIVUS Inc, Sanofi, Menarini Group, Auxilium Pharmaceuticals, Endo International and JW Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Avanafil, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Avanafil.
Report Scope
The Avanafil market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Avanafil market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Avanafil manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
VIVUS Inc
Sanofi
Menarini Group
Auxilium Pharmaceuticals
Endo International
JW Pharmaceutical
Segment by Type
50 mg Avanafil
100 mg Avanafil
200 mg Avanafil
Segment by Application
The Young Man
Middle-Aged Person
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Avanafil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Avanafil in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Avanafil market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Avanafil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Avanafil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Avanafil include VIVUS Inc, Sanofi, Menarini Group, Auxilium Pharmaceuticals, Endo International and JW Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Avanafil, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Avanafil.
Report Scope
The Avanafil market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Avanafil market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Avanafil manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
VIVUS Inc
Sanofi
Menarini Group
Auxilium Pharmaceuticals
Endo International
JW Pharmaceutical
Segment by Type
50 mg Avanafil
100 mg Avanafil
200 mg Avanafil
Segment by Application
The Young Man
Middle-Aged Person
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Avanafil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Avanafil in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Avanafil Market Overview
1.1 Product Overview and Scope of Avanafil
1.2 Avanafil Segment by Type
1.2.1 Global Avanafil Market Value Comparison by Type (2024-2030)
1.2.2 50 mg Avanafil
1.2.3 100 mg Avanafil
1.2.4 200 mg Avanafil
1.3 Avanafil Segment by Application
1.3.1 Global Avanafil Market Value by Application: (2024-2030)
1.3.2 The Young Man
1.3.3 Middle-Aged Person
1.3.4 Others
1.4 Global Avanafil Market Size Estimates and Forecasts
1.4.1 Global Avanafil Revenue 2019-2030
1.4.2 Global Avanafil Sales 2019-2030
1.4.3 Global Avanafil Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Avanafil Market Competition by Manufacturers
2.1 Global Avanafil Sales Market Share by Manufacturers (2019-2024)
2.2 Global Avanafil Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Avanafil Average Price by Manufacturers (2019-2024)
2.4 Global Avanafil Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Avanafil, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Avanafil, Product Type & Application
2.7 Avanafil Market Competitive Situation and Trends
2.7.1 Avanafil Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Avanafil Players Market Share by Revenue
2.7.3 Global Avanafil Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Avanafil Retrospective Market Scenario by Region
3.1 Global Avanafil Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Avanafil Global Avanafil Sales by Region: 2019-2030
3.2.1 Global Avanafil Sales by Region: 2019-2024
3.2.2 Global Avanafil Sales by Region: 2025-2030
3.3 Global Avanafil Global Avanafil Revenue by Region: 2019-2030
3.3.1 Global Avanafil Revenue by Region: 2019-2024
3.3.2 Global Avanafil Revenue by Region: 2025-2030
3.4 North America Avanafil Market Facts & Figures by Country
3.4.1 North America Avanafil Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Avanafil Sales by Country (2019-2030)
3.4.3 North America Avanafil Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Avanafil Market Facts & Figures by Country
3.5.1 Europe Avanafil Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Avanafil Sales by Country (2019-2030)
3.5.3 Europe Avanafil Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Avanafil Market Facts & Figures by Country
3.6.1 Asia Pacific Avanafil Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Avanafil Sales by Country (2019-2030)
3.6.3 Asia Pacific Avanafil Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Avanafil Market Facts & Figures by Country
3.7.1 Latin America Avanafil Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Avanafil Sales by Country (2019-2030)
3.7.3 Latin America Avanafil Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Avanafil Market Facts & Figures by Country
3.8.1 Middle East and Africa Avanafil Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Avanafil Sales by Country (2019-2030)
3.8.3 Middle East and Africa Avanafil Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Avanafil Sales by Type (2019-2030)
4.1.1 Global Avanafil Sales by Type (2019-2024)
4.1.2 Global Avanafil Sales by Type (2025-2030)
4.1.3 Global Avanafil Sales Market Share by Type (2019-2030)
4.2 Global Avanafil Revenue by Type (2019-2030)
4.2.1 Global Avanafil Revenue by Type (2019-2024)
4.2.2 Global Avanafil Revenue by Type (2025-2030)
4.2.3 Global Avanafil Revenue Market Share by Type (2019-2030)
4.3 Global Avanafil Price by Type (2019-2030)
5 Segment by Application
5.1 Global Avanafil Sales by Application (2019-2030)
5.1.1 Global Avanafil Sales by Application (2019-2024)
5.1.2 Global Avanafil Sales by Application (2025-2030)
5.1.3 Global Avanafil Sales Market Share by Application (2019-2030)
5.2 Global Avanafil Revenue by Application (2019-2030)
5.2.1 Global Avanafil Revenue by Application (2019-2024)
5.2.2 Global Avanafil Revenue by Application (2025-2030)
5.2.3 Global Avanafil Revenue Market Share by Application (2019-2030)
5.3 Global Avanafil Price by Application (2019-2030)
6 Key Companies Profiled
6.1 VIVUS Inc
6.1.1 VIVUS Inc Corporation Information
6.1.2 VIVUS Inc Description and Business Overview
6.1.3 VIVUS Inc Avanafil Sales, Revenue and Gross Margin (2019-2024)
6.1.4 VIVUS Inc Avanafil Product Portfolio
6.1.5 VIVUS Inc Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Avanafil Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Avanafil Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Menarini Group
6.3.1 Menarini Group Corporation Information
6.3.2 Menarini Group Description and Business Overview
6.3.3 Menarini Group Avanafil Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Menarini Group Avanafil Product Portfolio
6.3.5 Menarini Group Recent Developments/Updates
6.4 Auxilium Pharmaceuticals
6.4.1 Auxilium Pharmaceuticals Corporation Information
6.4.2 Auxilium Pharmaceuticals Description and Business Overview
6.4.3 Auxilium Pharmaceuticals Avanafil Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Auxilium Pharmaceuticals Avanafil Product Portfolio
6.4.5 Auxilium Pharmaceuticals Recent Developments/Updates
6.5 Endo International
6.5.1 Endo International Corporation Information
6.5.2 Endo International Description and Business Overview
6.5.3 Endo International Avanafil Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Endo International Avanafil Product Portfolio
6.5.5 Endo International Recent Developments/Updates
6.6 JW Pharmaceutical
6.6.1 JW Pharmaceutical Corporation Information
6.6.2 JW Pharmaceutical Description and Business Overview
6.6.3 JW Pharmaceutical Avanafil Sales, Revenue and Gross Margin (2019-2024)
6.6.4 JW Pharmaceutical Avanafil Product Portfolio
6.6.5 JW Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Avanafil Industry Chain Analysis
7.2 Avanafil Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Avanafil Production Mode & Process
7.4 Avanafil Sales and Marketing
7.4.1 Avanafil Sales Channels
7.4.2 Avanafil Distributors
7.5 Avanafil Customers
8 Avanafil Market Dynamics
8.1 Avanafil Industry Trends
8.2 Avanafil Market Drivers
8.3 Avanafil Market Challenges
8.4 Avanafil Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
